Lymphoproliferative disorders Clinical Trials

A listing of Lymphoproliferative disorders medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

Illinois

Chicago Illinois 60637

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Chicago Illinois 60611

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Massachusetts

Boston Massachusetts 02111

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

New York

New York New York 10065

A clinical research study of allogeneic Epstein-Barr virus-specific cytotoxic T lymphocytes for the treatment of Leukemia, Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific or Unspecified Childhood Solid Tumor, Protocol Specific

New York New York 10065

Patients are needed to participate in a clinical research study evaluating EBV-specific T-cells for the treatment of Non-Hodgkin's Lymphoma or Epstein-Barr Virus

Texas

Houston Texas 77030

Patients are needed to participate in a clinical research study of SGN-35

Japan

Nagoya-shi

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

Nagoya-shi

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

Nagoya-shi

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

Sendai-shi

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

Tokyo

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

View More ▼

Tokyo

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

United Kingdom

Liverpool Merseyside L7 8XP

A clinical trial seeking patients for a research study for the treatment of Multiple Myeloma, Plasma Cell Dyscrasia, Lymphoma or Lymphoproliferative Disorders